Page last updated: 2024-08-16

ranitidine and Chemotherapy-Induced Febrile Neutropenia

ranitidine has been researched along with Chemotherapy-Induced Febrile Neutropenia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Borthakur, G; Brail, L; Chow, KH; Cooley, S; Jackson, K; Moonan, L; Odenike, O; Rizzieri, DA; Wang, X1

Trials

1 trial(s) available for ranitidine and Chemotherapy-Induced Febrile Neutropenia

ArticleYear
An open-label phase 2 study of glycogen synthase kinase-3 inhibitor LY2090314 in patients with acute leukemia.
    Leukemia & lymphoma, 2016, Volume: 57, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Anemia; Anti-Ulcer Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; beta Catenin; Bone Marrow Cells; Carboplatin; Chemotherapy-Induced Febrile Neutropenia; Cohort Studies; Female; Glycogen Synthase Kinase 3; Heterocyclic Compounds, 3-Ring; Humans; Leukemia, Myeloid, Acute; Leukocytes, Mononuclear; Male; Maleimides; Middle Aged; Pain, Procedural; Pemetrexed; Protein Kinase Inhibitors; Ranitidine; Thrombocytopenia

2016